Hydronephrosis Treatment Market Size

Hydronephrosis Treatment Market Size

Hydronephrosis Treatment Market size was valued at around USD 2.4 billion in 2023 and is expected to reach around USD 4.9 billion by 2032 at a CAGR of 8.2% during the forecast period. The growing prevalence of kidney diseases is anticipated to be among the primary factor propelling the growth of the market.

To get key market trends

  Download Free Sample

Hydronephrosis treatment refers to the medical interventions and procedures aimed at managing and resolving the condition of hydronephrosis, which is characterized by the swelling or enlargement of one or both kidneys due to the buildup of urine caused by an obstruction or blockage in the urinary tract.

The growing prevalence of kidney diseases, including chronic kidney disease (CKD), is a significant health concern globally. Factors such as diabetes, hypertension, obesity, and family history contribute to the increasing incidence of CKDs. According to the Centers for Disease Control and Prevention (CDC), in 2023, more than 1 in 7 U.S. adults, about 35.5 million people, or 14% are estimated to have CKD. CKD plays a substantial role in the development of end-stage renal disease (ESRD) due to the progressive nature of kidney damage associated with CKDs.
 

For example, in the U.S., the number of reported ESRD cases increased by 41.8% from 2000 to 2019, with the number of prevalent cases approximately doubling during this period, according to the CDC. These statistics underscores the growing burden of kidney diseases globally and emphasize the need for increased awareness, early detection, and effective management strategies to address this public health issue.